VISCO, VALERIA
 Distribuzione geografica
Continente #
AS - Asia 5.508
NA - Nord America 1.389
EU - Europa 762
SA - Sud America 240
AF - Africa 46
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.949
Nazione #
HK - Hong Kong 4.356
US - Stati Uniti d'America 1.334
SG - Singapore 589
IT - Italia 282
CN - Cina 195
BR - Brasile 183
VN - Vietnam 157
RU - Federazione Russa 155
DE - Germania 86
FR - Francia 47
IN - India 45
GB - Regno Unito 35
CA - Canada 30
BD - Bangladesh 27
KR - Corea 25
JP - Giappone 23
NL - Olanda 23
SE - Svezia 23
AT - Austria 20
FI - Finlandia 20
ES - Italia 19
AR - Argentina 18
MX - Messico 16
IQ - Iraq 15
IE - Irlanda 14
PL - Polonia 13
TR - Turchia 13
EC - Ecuador 12
ZA - Sudafrica 12
ID - Indonesia 9
VE - Venezuela 8
CO - Colombia 7
KE - Kenya 6
PK - Pakistan 6
SA - Arabia Saudita 6
EG - Egitto 5
IR - Iran 5
JO - Giordania 5
PH - Filippine 5
TN - Tunisia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
LT - Lituania 4
MA - Marocco 4
AL - Albania 3
AU - Australia 3
CZ - Repubblica Ceca 3
IL - Israele 3
NI - Nicaragua 3
NP - Nepal 3
PY - Paraguay 3
RO - Romania 3
BO - Bolivia 2
CH - Svizzera 2
CY - Cipro 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
LB - Libano 2
MY - Malesia 2
NG - Nigeria 2
UA - Ucraina 2
UY - Uruguay 2
AO - Angola 1
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LY - Libia 1
MT - Malta 1
MU - Mauritius 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.949
Città #
Hong Kong 4.354
Singapore 305
San Jose 292
Dallas 176
Ashburn 155
Council Bluffs 57
Beijing 53
Chandler 49
Ho Chi Minh City 49
New York 47
Naples 41
Munich 40
Hanoi 39
The Dalles 39
Lauterbourg 38
Princeton 34
Los Angeles 31
Fisciano 29
Moscow 29
Nuremberg 24
São Paulo 23
Santa Clara 22
Tokyo 22
Salerno 20
Stockholm 19
Ann Arbor 18
Denver 18
Domicella 18
Frankfurt am Main 17
Orem 17
Milan 16
Boardman 15
Dublin 13
Montreal 13
Turku 13
Brooklyn 12
Seoul 12
London 11
Warsaw 11
Amsterdam 10
Atlanta 9
Buffalo 9
Da Nang 9
Houston 9
San Francisco 9
Sarno 9
Vienna 8
Belo Horizonte 7
Biên Hòa 7
Chennai 7
Haiphong 7
Phoenix 7
Querétaro 7
Rome 7
Charlotte 6
Chicago 6
Manchester 6
Montoro 6
Seattle 6
Turin 6
West Jordan 6
Ankara 5
Bengaluru 5
City of London 5
Guangzhou 5
Helsinki 5
Nairobi 5
Poplar 5
Tashkent 5
Washington 5
Amman 4
Baghdad 4
Boston 4
Caracas 4
Jacksonville 4
Jeddah 4
Johannesburg 4
Milwaukee 4
Mumbai 4
Norwalk 4
Shanghai 4
Tehran 4
Toronto 4
Wilmington 4
Zelarino 4
Afragola 3
Andover 3
Brasília 3
Cairo 3
Canoas 3
Cardito 3
Cleveland 3
Curitiba 3
Feira de Santana 3
Goiânia 3
Izmir 3
Jakarta 3
Joinville 3
Madrid 3
Managua 3
Totale 6.504
Nome #
589 THE EFFECT OF DAPAGLIFLOZIN ON SYMPTOMS, QUALITY OF LIFE AND ECHOCARDIOGRAPHIC PARAMETERS IN A REAL-WORLD POPULATION OF HFREF PATIENTS 895
Difficult-to-control hypertension: identification of clinical predictors and use of ICT-based integrated care to facilitate blood pressure control 884
Cardiovascular Implications of microRNAs in Coronavirus Disease 2019 700
Plasma miR-1-3p levels predict severity in hospitalized COVID- 19 patients 572
Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve 465
Sacubitril/Valsartan vs. Standard Medical Therapy on Exercise Capacity in HFrEF Patients 266
Technological Developments, Exercise Training Programs, and Clinical Outcomes in Cardiac Telerehabilitation in the Last Ten Years: A Systematic Review 261
Retrospective Study on Short-Term Reverse Cardiac Remodeling in Obese Patients Undergoing Sleeve Gastrectomy 253
Serum uric acid and left ventricular mass in essential hypertension 249
The favourable alliance between cardiomems and levosimendan in patients with advanced heart failure 221
Vitamin D, parathyroid hormone and cardiovascular risk: The good, the bad and the ugly 216
Cardiovascular Nursing in Rehabilitative Cardiology: A Review 212
An explainable model for predicting Worsening Heart Failure based on genetic programming 145
719 CIRCULATING SORTILIN LEVELS ARE INCREASED IN PATIENTS RECEIVING LONG-TERM WARFARIN AND ITS INHIBITION ATTENUATES WARFARIN-INDUCED VASCULAR CALCIFICATION 128
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems 121
A Multistep Approach to Deal With Advanced Heart Failure: A Case Report on the Positive Effect of Cardiac Contractility Modulation Therapy on Pulmonary Pressure Measured by CardioMEMS 118
C2CD4B Evokes Oxidative Stress and Vascular Dysfunction via a PI3K/Akt/PKCα–Signaling Pathway 116
Whole-Exome Sequencing Revealed New Candidate Genes for Human Dilated Cardiomyopathy 115
Interventions to Address Cardiovascular Risk in Obese Patients: Many Hands Make Light Work 108
Artificial intelligence as a business partner in cardiovascular precision medicine: An emerging approach for disease detection and treatment optimization 104
Chronic Kidney Disease with Mineral Bone Disorder and Vascular Calcification: An Overview 98
A Novel Combination of High-Load Omega-3 Lysine Complex (AvailOm®) and Anthocyanins Exerts Beneficial Cardiovascular Effects 91
We are What We Eat: Impact of Food from Short Supply Chain on Metabolic Syndrome 90
The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers 86
Epigenetic mechanisms underlying the beneficial effects of cardiac rehabilitation. An overview from the working groups of “cellular and molecular biology of the heart” and “cardiac rehabilitation and cardiovascular prevention” of the Italian Society of Cardiology (SIC) 82
Vitamin D: A Bridge between Kidney and Heart. 81
Artificial intelligence in cardiovascular prevention: new ways will open new doors 81
Acute heart failure: mechanisms and pre-clinical models-a Scientific Statement of the ESC Working Group on Myocardial Function 75
Serum parathormone, vitamin D and cardiovascular risk factors and markers: A pilot study 74
Larger Blood Pressure Reduction by Fixed-Dose Compared to Free Dose Combination Therapy of ACE Inhibitor and Calcium Antagonist in Hypertensive Patients 71
The role of oxidative stress in cardiovascular aging and cardiovascular diseases 71
The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is better 68
Frail hypertensive older adults with prediabetes and chronic kidney disease: insights on organ damage and cognitive performance - preliminary results from the CARYATID study 67
The metabolic role of grk2 in insulin resistance and associated conditions 67
Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function 62
It is easy to see, but it is better to foresee: a case report on the favourable alliance between CardioMEMS and levosimendan 58
Aortic Remodeling in Patients with Arterial Hypertension: Pathophysiological Mechanisms, Therapeutic Interventions and Preventive Strategies—A Position Paper from the Heart and Hypertension Working Group of the Italian Society of Hypertension 58
Endothelial microRNAs in INOCA patients with diabetes mellitus 53
Accuracy of home blood pressure measurement: the ACCURAPRESS study - a proposal of Young Investigator Group of the Italian Hypertension Society (Societa Italiana dell'Ipertensione Arteriosa) 53
Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEF 51
SGLT2 inhibitors and GLP-1 receptor agonists: which is the best anti-frailty drug? 51
Vericiguat in heart failure with reduced ejection fraction: hope or solid reality? 49
Exercise Echocardiography of Left Ventricular Diastolic Function in Healthy Subjects: Insights From the RIGHT-NET 48
Prediabetes Increases the Risk of Frailty in Prefrail Older Adults With Hypertension: Beneficial Effects of Metformin 47
GRK2 and Mitochondrial Dynamics in Cardiovascular Health and Disease 44
Subclinical left ventricular dysfunction assessed by global longitudinal strain correlates with mild cognitive impairment in hypertensive patients 39
Plasma miR-1-3p levels predict severity in hospitalized COVID-19 patients 36
Lung ultrasound in cardiac rehabilitation: expert consensus on protocols, clinical use, and integration into patient management from the working group on cardiac rehabilitation and cardiovascular prevention of the Italian society of cardiology 33
Evaluation of the Effectiveness of a Cardiac Telerehabilitation Program in Chronic Heart Failure: Design and Rationale of the TELEREHAB-HF Study 33
Mitochondrial accumulation of GRK2 as a protective mechanism against hypoxia-induced endothelial dysfunction 28
Unraveling the risk factors for type II diabetes in severe obese patients with indication for bariatric Surgery: retrospective analysis 26
Analysis of a Real-World Population Participating in a Cardiac Rehabilitation Program: Cognitive Impairment, Functional Capacity, and Therapy Titration 12
Artificial intelligence-based remote monitoring for chronic heart failure: design and rationale of the SMART-CARE study 4
Totale 8.036
Categoria #
all - tutte 18.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.364


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 1 1
2021/202255 0 0 0 0 0 0 14 3 4 3 6 25
2022/2023118 9 18 8 13 15 18 0 12 15 1 6 3
2023/2024214 6 15 13 11 21 26 16 8 4 12 9 73
2024/2025793 9 15 14 50 56 78 180 47 118 27 93 106
2025/20266.792 1.327 2.124 1.317 260 379 180 388 107 251 332 127 0
Totale 8.036